Eudald Felip
Overview
Explore the profile of Eudald Felip including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Soosaipillai G, Wu A, Dettorre G, Diamantis N, Chester J, Moss C, et al.
Ther Adv Med Oncol
. 2021 Sep;
13:17588359211042224.
PMID: 34497669
Background: Specialist palliative care team (SPCT) involvement has been shown to improve symptom control and end-of-life care for patients with cancer, but little is known as to how these have...
22.
Pinato D, Scotti L, Gennari A, Colomba-Blameble E, Dolly S, Loizidou A, et al.
Eur J Cancer
. 2021 May;
150:190-202.
PMID: 33932726
Background: Despite high contagiousness and rapid spread, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected nations. Within Europe (EU), the United Kingdom (UK) is...
23.
Dettorre G, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, et al.
J Immunother Cancer
. 2021 Mar;
9(3).
PMID: 33753569
Background: Patients with cancer are particularly susceptible to SARS-CoV-2 infection. The systemic inflammatory response is a pathogenic mechanism shared by cancer progression and COVID-19. We investigated systemic inflammation as a...
24.
Gutierrez-Chamorro L, Felip E, Ezeonwumelu I, Margeli M, Ballana E
Trends Microbiol
. 2021 Feb;
29(9):836-848.
PMID: 33618979
Besides its prominent role in cell proliferation, cyclin-dependent kinases (CDKs) are key players in viral infections as both DNA and RNA viruses modify CDK function to favor viral replication. Recently,...
25.
Felip E, Llobera L, Perez-Mana C, Quintela D, Guasch I, Margeli M, et al.
Breast Care (Basel)
. 2020 Nov;
15(5):548-552.
PMID: 33224001
Background: Palbociclib is a specific inhibitor of cyclin-dependent kinases 4 and 6 that is approved for the treatment of advanced or metastatic breast cancer patients. Despite a good toxicity profile...
26.
Pinato D, Zambelli A, Aguilar-Company J, Bower M, Sng C, Salazar R, et al.
Cancer Discov
. 2020 Aug;
PMID: 32737082
The SARS-Cov-2 pandemic significantly impacted on oncology practice across the globe. There is uncertainty as to the contribution of patients' demographics and oncological features on severity and mortality from Covid-19...
27.
Castellvi M, Felip E, Ezeonwumelu I, Badia R, Garcia-Vidal E, Pujantell M, et al.
Cancers (Basel)
. 2020 Jul;
12(7).
PMID: 32610575
The authors wish you make the following corrections to this paper[...].
28.
Castellvi M, Felip E, Ezeonwumelu I, Badia R, Garcia-Vidal E, Pujantell M, et al.
Cancers (Basel)
. 2020 Mar;
12(3).
PMID: 32197329
Sterile alpha motif and histidine-aspartic acid domain-containing protein 1 (SAMHD1) is a dNTP triphosphohydrolase involved in the regulation of the intracellular dNTP pool, linked to viral restriction, cancer development and...
29.
Hardy-Werbin M, Quiroga V, Cirauqui B, Romeo M, Felip E, Teruel I, et al.
Sci Rep
. 2019 Sep;
9(1):12760.
PMID: 31484985
T-DM1 is an antibody drug conjugate that combines trastuzumab with emtansine via a stable thioether linker. In two phase III clinical trials, EMILIA and TH3RESA, T-DM1 was shown to be...
30.
Garcia-Vidal E, Badia R, Pujantell M, Castellvi M, Felip E, Clotet B, et al.
Antiviral Res
. 2019 May;
168:18-27.
PMID: 31077767
Midostaurin is a multi-kinase inhibitor with antineoplastic activity. We assessed the capacity of midostaurin to affect early and late steps of HIV-1 infection and to reactivate HIV-1 latently infected cells,...